Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor for LV Remodeling in STEMI (HEALING-AMI)
NCT02224534Phase 4Unknown
- Sponsor
- Gyeongsang National University Hospital
- Start
- Oct 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of ticagrelor in ST-segment elevation myocardial infarction (STEMI), sponsored by Gyeongsang National University Hospital. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02224534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02224534.